IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v16y2025i1d10.1038_s41467-025-60495-w.html
   My bibliography  Save this article

Prime editor with rational design and AI-driven optimization for reverse editing window and enhanced fidelity

Author

Listed:
  • Chao Yang

    (Tianjin Medical University Cancer Institute and Hospital
    National Clinical Research Center for Cancer
    State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine
    Tianjin Key Laboratory of Digestive Cancer)

  • Qingxiao Fang

    (Tianjin Medical University Cancer Institute and Hospital
    National Clinical Research Center for Cancer
    State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine
    Tianjin Key Laboratory of Digestive Cancer)

  • Mengyu Li

    (Tianjin Medical University Cancer Institute and Hospital
    National Clinical Research Center for Cancer
    State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine
    Tianjin Key Laboratory of Digestive Cancer)

  • Jin Zhang

    (Tianjin Medical University Cancer Institute and Hospital
    National Clinical Research Center for Cancer
    State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine
    Tianjin Key Laboratory of Digestive Cancer)

  • Rui Li

    (Tianjin University of Science and Technology)

  • Tianxing Zhou

    (Tianjin Medical University Cancer Institute and Hospital
    National Clinical Research Center for Cancer
    State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine
    Tianjin Key Laboratory of Digestive Cancer)

  • Keshan Wang

    (Huazhong University of Science and Technology)

  • Jie Deng

    (Huazhong University of Science and Technology)

  • Xiuchao Wang

    (Tianjin Medical University Cancer Institute and Hospital
    National Clinical Research Center for Cancer
    State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine
    Tianjin Key Laboratory of Digestive Cancer)

  • Chongbiao Huang

    (Tianjin Medical University Cancer Institute and Hospital
    National Clinical Research Center for Cancer
    State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine
    Tianjin Key Laboratory of Digestive Cancer)

  • Yukuan Feng

    (Tianjin Medical University Cancer Institute and Hospital
    National Clinical Research Center for Cancer
    State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine
    Tianjin Key Laboratory of Digestive Cancer)

  • Xiaoping Zhang

    (Huazhong University of Science and Technology)

  • Lei Shi

    (State Key Laboratory of Experimental Hematology
    Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education)
    Key Laboratory of Immune Microenvironment and Disease (Ministry of Education)
    The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics)

  • Changhao Bi

    (Chinese Academy of Sciences)

  • Xueli Zhang

    (Chinese Academy of Sciences)

  • Jun Yu

    (Tianjin Medical University Cancer Institute and Hospital
    National Clinical Research Center for Cancer
    State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine
    Tianjin Key Laboratory of Digestive Cancer)

  • Jihui Hao

    (Tianjin Medical University Cancer Institute and Hospital
    National Clinical Research Center for Cancer
    State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine
    Tianjin Key Laboratory of Digestive Cancer)

Abstract

Prime editing (PE) is a precise tool for introducing genetic mutations in eukaryotes. Extending the efficient editing scope and mitigating undesired byproducts are possible. We introduce reverse PE (rPE), a SpCas9-directed variant that enabled DNA editing at the 3′ direction of HNH-mediated nick site. The rPE leveraging nCas9-D10A and rPE gRNA targeting the 5′ direction of HNH-mediated nick site inscribes genetic alterations, achieving a reverse editing window and potentially high fidelity. HNH and reverse transcriptase engineered using protein language models in conjunction with La facilitate circular erPEmax and erPE7max, achieving editing efficiency up to 44.41% without nick gRNA or positive selection. Furthermore, our findings underscore the capability of rPE in inserting functionally enhanced variant (PIK3CDE527G) for cell therapy. By expanding the editing scope and enhancing genomic manipulability, rPE represents a meaningful advancement in prime editing, improving its utility for research and therapeutic applications.

Suggested Citation

  • Chao Yang & Qingxiao Fang & Mengyu Li & Jin Zhang & Rui Li & Tianxing Zhou & Keshan Wang & Jie Deng & Xiuchao Wang & Chongbiao Huang & Yukuan Feng & Xiaoping Zhang & Lei Shi & Changhao Bi & Xueli Zhan, 2025. "Prime editor with rational design and AI-driven optimization for reverse editing window and enhanced fidelity," Nature Communications, Nature, vol. 16(1), pages 1-14, December.
  • Handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-60495-w
    DOI: 10.1038/s41467-025-60495-w
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-025-60495-w
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-025-60495-w?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Andrew V. Anzalone & Peyton B. Randolph & Jessie R. Davis & Alexander A. Sousa & Luke W. Koblan & Jonathan M. Levy & Peter J. Chen & Christopher Wilson & Gregory A. Newby & Aditya Raguram & David R. L, 2019. "Search-and-replace genome editing without double-strand breaks or donor DNA," Nature, Nature, vol. 576(7785), pages 149-157, December.
    2. Jun Yan & Paul Oyler-Castrillo & Purnima Ravisankar & Carl C. Ward & Sébastien Levesque & Yangwode Jing & Danny Simpson & Anqi Zhao & Hui Li & Weihao Yan & Laine Goudy & Ralf Schmidt & Sabrina C. Soll, 2024. "Improving prime editing with an endogenous small RNA-binding protein," Nature, Nature, vol. 628(8008), pages 639-647, April.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Youcai Xiong & Yinyu Su & Ruigao He & Xiaosong Han & Sheng Li & Minghuan Liu & Xiaoning Xi & Zijia Liu & Heng Wang & Shengsong Xie & Xuewen Xu & Kui Li & Jifeng Zhang & Jie Xu & Xinyun Li & Shuhong Zh, 2025. "EXPERT expands prime editing efficiency and range of large fragment edits," Nature Communications, Nature, vol. 16(1), pages 1-13, December.
    2. Ronghong Liang & Shan Wang & Yibo Cai & Zhenyu Li & Ka Ming Li & Jingjing Wei & Chao Sun & Haocheng Zhu & Kunling Chen & Caixia Gao, 2025. "Circular RNA-mediated inverse prime editing in human cells," Nature Communications, Nature, vol. 16(1), pages 1-11, December.
    3. Qichen Yuan & Hongzhi Zeng & Tyler C. Daniel & Qingzhuo Liu & Yongjie Yang & Emmanuel C. Osikpa & Qiaochu Yang & Advaith Peddi & Liliana M. Abramson & Boyang Zhang & Yong Xu & Xue Gao, 2024. "Orthogonal and multiplexable genetic perturbations with an engineered prime editor and a diverse RNA array," Nature Communications, Nature, vol. 15(1), pages 1-12, December.
    4. Louis C. Dacquay & Panagiotis Antoniou & Astrid Mentani & Niklas Selfjord & Hanna Mårtensson & Pei-Pei Hsieh & Salman Mustfa & George Thom & Sandra Wimberger & Mike Firth & Nina Akrap & Marcello Mares, 2025. "Dual inhibition of DNA-PK and Polϴ boosts precision of diverse prime editing systems," Nature Communications, Nature, vol. 16(1), pages 1-11, December.
    5. Yidian Fu & Xiaoyu He & Liang Ma & Xin D. Gao & Pengpeng Liu & Hanhan Shi & Peiwei Chai & Shengfang Ge & Renbing Jia & David R. Liu & Xianqun Fan & Zhi Yang, 2025. "In vivo prime editing rescues photoreceptor degeneration in nonsense mutant retinitis pigmentosa," Nature Communications, Nature, vol. 16(1), pages 1-16, December.
    6. Qiwen Su-Tobon & Jiayi Fan & Michael Goldstein & Kevin Feeney & Hongyuan Ren & Patrick Autissier & Peiyi Wang & Yingzi Huang & Udayan Mohanty & Jia Niu, 2025. "CRISPR-Hybrid: A CRISPR-Mediated Intracellular Directed Evolution Platform for RNA Aptamers," Nature Communications, Nature, vol. 16(1), pages 1-13, December.
    7. Lisa Maria Riedmayr & Klara Sonnie Hinrichsmeyer & Stefan Bernhard Thalhammer & David Manuel Mittas & Nina Karguth & Dina Yehia Otify & Sybille Böhm & Valentin Johannes Weber & Michael David Bartosche, 2023. "mRNA trans-splicing dual AAV vectors for (epi)genome editing and gene therapy," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    8. Tian Zhou & Xinyi Zhu & Zhizhong Ye & Yong-Fei Wang & Chao Yao & Ning Xu & Mi Zhou & Jianyang Ma & Yuting Qin & Yiwei Shen & Yuanjia Tang & Zhihua Yin & Hong Xu & Yutong Zhang & Xiaoli Zang & Huihua D, 2022. "Lupus enhancer risk variant causes dysregulation of IRF8 through cooperative lncRNA and DNA methylation machinery," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    9. Guiquan Zhang & Yao Liu & Shisheng Huang & Shiyuan Qu & Daolin Cheng & Yuan Yao & Quanjiang Ji & Xiaolong Wang & Xingxu Huang & Jianghuai Liu, 2022. "Enhancement of prime editing via xrRNA motif-joined pegRNA," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    10. Raed Ibraheim & Phillip W. L. Tai & Aamir Mir & Nida Javeed & Jiaming Wang & Tomás C. Rodríguez & Suk Namkung & Samantha Nelson & Eraj Shafiq Khokhar & Esther Mintzer & Stacy Maitland & Zexiang Chen &, 2021. "Self-inactivating, all-in-one AAV vectors for precision Cas9 genome editing via homology-directed repair in vivo," Nature Communications, Nature, vol. 12(1), pages 1-17, December.
    11. Ronghao Chen & Yu Cao & Yajing Liu & Dongdong Zhao & Ju Li & Zhihui Cheng & Changhao Bi & Xueli Zhang, 2023. "Enhancement of a prime editing system via optimal recruitment of the pioneer transcription factor P65," Nature Communications, Nature, vol. 14(1), pages 1-8, December.
    12. Xiangyang Li & Guiquan Zhang & Shisheng Huang & Yao Liu & Jin Tang & Mingtian Zhong & Xin Wang & Wenjun Sun & Yuan Yao & Quanjiang Ji & Xiaolong Wang & Jianghuai Liu & Shiqiang Zhu & Xingxu Huang, 2023. "Development of a versatile nuclease prime editor with upgraded precision," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    13. Helena Escobar & Silvia Di Francescantonio & Julia Smirnova & Robin Graf & Stefanie Müthel & Andreas Marg & Alexej Zhogov & Supriya Krishna & Eric Metzler & Mina Petkova & Oliver Daumke & Ralf Kühn & , 2025. "Gene-editing in patient and humanized-mice primary muscle stem cells rescues dysferlin expression in dysferlin-deficient muscular dystrophy," Nature Communications, Nature, vol. 16(1), pages 1-17, December.
    14. Martin Peterka & Nina Akrap & Songyuan Li & Sandra Wimberger & Pei-Pei Hsieh & Dmitrii Degtev & Burcu Bestas & Jack Barr & Stijn Plassche & Patricia Mendoza-Garcia & Saša Šviković & Grzegorz Sienski &, 2022. "Harnessing DSB repair to promote efficient homology-dependent and -independent prime editing," Nature Communications, Nature, vol. 13(1), pages 1-9, December.
    15. Zhaohui Zhong & Guanqing Liu & Zhongjie Tang & Shuyue Xiang & Liang Yang & Lan Huang & Yao He & Tingting Fan & Shishi Liu & Xuelian Zheng & Tao Zhang & Yiping Qi & Jian Huang & Yong Zhang, 2023. "Efficient plant genome engineering using a probiotic sourced CRISPR-Cas9 system," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    16. Qichen Yuan & Xue Gao, 2022. "Multiplex base- and prime-editing with drive-and-process CRISPR arrays," Nature Communications, Nature, vol. 13(1), pages 1-13, December.
    17. Jidong Fei & Dongdong Zhao & Caiyi Pang & Ju Li & Siwei Li & Wentao Qiao & Juan Tan & Changhao Bi & Xueli Zhang, 2025. "Mismatch prime editing gRNA increased efficiency and reduced indels," Nature Communications, Nature, vol. 16(1), pages 1-10, December.
    18. Huawei Tong & Haoqiang Wang & Xuchen Wang & Nana Liu & Guoling Li & Danni Wu & Yun Li & Ming Jin & Hengbin Li & Yinghui Wei & Tong Li & Yuan Yuan & Linyu Shi & Xuan Yao & Yingsi Zhou & Hui Yang, 2024. "Development of deaminase-free T-to-S base editor and C-to-G base editor by engineered human uracil DNA glycosylase," Nature Communications, Nature, vol. 15(1), pages 1-12, December.
    19. You Li & Zhiqiang Li & Ruiling Chen & Min Lian & Hanxiao Wang & Yiran Wei & Zhengrui You & Jun Zhang & Bo Li & Yikang Li & Bingyuan Huang & Yong Chen & Qiaoyan Liu & Zhuwan Lyu & Xueying Liang & Qi Mi, 2023. "A regulatory variant at 19p13.3 is associated with primary biliary cholangitis risk and ARID3A expression," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    20. Kun Jia & Yan-ru Cui & Shisheng Huang & Peihong Yu & Zhengxing Lian & Peixiang Ma & Jia Liu, 2022. "Phage peptides mediate precision base editing with focused targeting window," Nature Communications, Nature, vol. 13(1), pages 1-10, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-60495-w. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.